A New Jersey pharmaceutical company is recalling more than 230,000 bottles of antidepressants after detecting a chemical that can cause cancer.
The recall impacts duloxetine sold by Rising Pharmaceuticals. Duloxetine is a delayed-release medication that is often prescribed to treat depression and generalized anxiety disorder.
Headquartered in East Brunswick, Rising Pharmaceuticals issued the voluntary recall on Nov. 19.
However, it was only earlier this month that the U.S. Food and Drug Administration classified it as a Class Two recall — that means exposure to the recalled medication may cause “temporary or medically reversible” health effects.
According to the FDA, the “presence” of a cancer-causing chemical was found in the pills.
The FDA said that nitrosamine impurities (N-nitroso-duloxetine) above acceptable intake levels had been detected in the medication.
Nitrosamines are organic compounds found in low levels in food and water. People who take drugs with acceptable levels of these chemicals are not at higher risk of cancer.
But in higher concentrations, nitrosamines have been linked to a significant increase in the risk of developing cancers.
If you or a loved one has suffered losses due to ingesting this product, you may be entitled to compensation. To learn more, contact the trusted personal injury attorneys at Breslin and Breslin today.
